Rare pulmonary neoplasms

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Rare primary neoplasms of the lung account for less than 1% of all primary lung cancers. These pulmonary rumors are usually metastatic. Accurate histopathologic studies and detailed clinical history are essential to confirm the diagnosis of unusual primary neoplasms of the lung. Rare pulmonary neoplasms are subdivided into six major histopathologic groups and include lymphoid tumors, soft tissue sarcomas, salivary gland tumors, mixed epithelial/mesenchymal tumors, ectopic tissue tumors, and undetermined histogenetic tumors. Surgical resection, when possible, is the treatment of choice for rare pulmonary neoplasms. The effects of adjuvant therapy on long- term survival and disease-free interval is not known because of the rarity of these neoplasms. Overall survival is better when compared with primary bronchogenic carcinoma. Therefore, aggressive surgical treatment of rare primary neoplasms of the lung is warranted.

Original languageEnglish (US)
Pages (from-to)405-415
Number of pages11
JournalSeminars in Respiratory and Critical Care Medicine
Issue number4
StatePublished - 1997
Externally publishedYes


  • Adjuvant therapy
  • Pulmonary neoplasms
  • Rare neoplasms
  • Surgery

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Rare pulmonary neoplasms'. Together they form a unique fingerprint.

Cite this